RVL Pharmaceuticals plc Lease, Cost
RVL Pharmaceuticals plc reported Lease, Cost of $1.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-03-20
- RVL Pharmaceuticals plc lease, cost for the quarter ending 2019-12-31 was $79.48K.
- RVL Pharmaceuticals plc lease, cost for the quarter ending 2019-09-30 was $668.83K.
- RVL Pharmaceuticals plc lease, cost for the quarter ending 2019-06-30 was $676.77K.
- RVL Pharmaceuticals plc lease, cost for the quarter ending 2019-03-31 was $631.91K.
- RVL Pharmaceuticals plc lease, cost for fiscal 2022 was $1.16M, a 23.39% decline from fiscal 2021.
- RVL Pharmaceuticals plc lease, cost for fiscal 2021 was $1.52M, a 8.39% decline from fiscal 2020.
- RVL Pharmaceuticals plc lease, cost for fiscal 2020 was $1.66M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $1.16M 10-K · filed 2023-03-20 | ||||
| 2021-12-31 | $1.52M 10-K · filed 2023-03-20 | $1.52M 10-K · filed 2022-03-30 | |||
| 2020-12-31 | $1.66M 10-K · filed 2022-03-30 | $2.15M 10-K · filed 2021-03-30 | |||
| 2019-12-31 | $79.48K derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $748.32K derived: sum of 2 quarters · filed 2021-09-08 | $1.43M derived: sum of 3 quarters · filed 2021-09-08 | $2.06M 8-K · filed 2021-09-08 | $2.56M 10-K · filed 2020-03-19 |
| 2019-09-30 | $668.83K 10-Q · filed 2019-11-14 | $1.35M derived: sum of 2 quarters · filed 2019-11-14 | $1.98M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $676.77K 10-Q · filed 2019-08-08 | $1.31M 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $631.91K 10-Q · filed 2019-05-09 |